Posted 9/13/2015 12:47 PM (GMT 0)
Due to my diagnosis (cT3a, G9 5+4) I selected primary RT with ADT2 (Lupron and Casodex). Approaching 2 1/2 years on ADT, and over two years since RT finished. All of those thrills, chills, and excitement were at Vanderbilt University Health System in Nashville. (For me, ADT side effects are burdensome. I've been blessed to have essentially no side effects from my aggressive radiation treatment).
My uro onc there started my ADT2, the RO was on board with that. They were both in the same hospital system and shared info/consultations. The MO there said she was ok with it too, but thought the uro could continue the ADT2 plan. Those three were my "team", and I made sure they all agreed before we started anything.
We moved to another state subsequently. Since I had no uro here, RT is history, and all of my future treatments are in the MO realm anyway, I now have a University of Michigan MO managing my treatment plan. That makes sense for me.
The only thing with MOs, is they're generally involved in the recurrence/resistant/metastatic phase and have that long term permanent/progressive orientation. I'm still in primary treatment, so it's that perspective that I need to keep on the front burner. As in, I want OFF of ADT!
It depends probably upon where one is in the whole spectrum of treatment plans.
Jerry